Skip to main content

Westpac Banking Corp 6-K, filed Oct 12, 2021

Westpac Banking Corp (WEBNF)

6-K 2021-10-12 For: 2021-10-12
View Original
Added on April 06, 2026

About this 6-K

Westpac Banking Corp filed this 6-K on October 12, 2021.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

October 12, 2021

Commission File Number 1-10167

WESTPAC BANKING CORPORATION

(Translation of registrant’s name into English)

275 KENT STREET, SYDNEY, NEW SOUTH WALES 2000, AUSTRALIA

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports

under cover of Form 20-F or Form 40-F.

Form 20-F          x            Form 40-F       ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

Index to Exhibits

ExhibitNo. Description
1 ASX Release – Notable items affecting Westpac’s Second Half 2021 to reduce profit by $1.3bn

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

WESTPAC BANKING CORPORATION
(Registrant)
Date: October 12, 2021 By: /s/ Yvette Adiguzel
Yvette Adiguzel
Tier One Attorney

Exhibit 1

Level 18, 275 Kent Street

Sydney, NSW, 2000

ASX

Release

12 October 2021

Notableitems affecting Westpac**’s Second Half 2021 (2H21) to reduceprofit by $1.3bn**

Westpac today announced that its reported net profit and cash earnings in 2H21 will be reduced by $1.3 billion (after tax) due to notable items. The notable items after tax include:

· a<br> $965m write-down of assets (goodwill, capitalised software and certain other assets) in Westpac<br> Institutional Bank (WIB) following their annual impairment test;
· additional<br> provisions for customer refunds, payments, associated costs, and litigation provisions of<br> $172m;
--- ---
· previously<br> announced separation and transaction costs along with a deferred tax asset write-off related<br> to the agreed sale of Westpac Life Insurance Services Limited (WLIS) of $267m^1^;<br> and
--- ---
· other<br> costs associated with the divestment of the Group’s Specialist Businesses of $24m.
--- ---

These charges were partly offset by:

· a<br> gain on sale of Westpac General Insurance, $55m; and
· a<br> reversal of the previous write-downs associated with Westpac Pacific as the business is no<br> longer held for sale, $54m.
--- ---

In aggregate these items are estimated to reduce the Group’s CET1 capital ratio by around 15 basis points^2^, noting that the write-down of goodwill and capitalised software has no net impact on regulatory capital as they are already capital deductions.

Details of notable items in Second Half 2021 are in Appendix 1 and a summary of line item impacts is in Appendix 2. A more detailed breakdown of these notable items, including additional Non-interest income and Expense details, will be provided with our Full Year 2021 results.

Changes to information in Westpac’s 2021 Full Year FinancialResults

In First Half 2021 we introduced a “Held for sale” designation for businesses under sale agreements. In Second Half 2021 the following businesses (previously in Held for sale) were sold and are not included in ‘Held for sale’ after their sale date:

· Vendor<br> Finance;
· Westpac<br> General Insurance; and
--- ---
· Westpac<br> Lenders Mortgage Insurance.
--- ---

In addition, Westpac Pacific is no longer in Held for sale following Westpac’s announcement on 22 September 2021 that the sale to Kina Securities Limited would no longer proceed.

^1^ This compares to the post tax loss of c.$0.3bn for FY21 disclosed on 9/8/21. A further loss on sale is expected to be recorded in FY22 when the sale of WLIS is completed.

^2^ At June 30 2021.

Page 2 of 4

Following announced sales through Second Half 2021, the following businesses will now be presented under the “Held for sale” designation:

· Westpac<br> Life Insurance Services Limited;
· Westpac<br> Life-NZ-Limited; and
--- ---
· Motor<br> vehicle dealer finance and novated leasing.
--- ---

In Section 5 of the Full Year 2021 Results we will expand our disclosure to outline the cash earnings contribution of businesses sold and currently Held for sale in Financial Year 2021.

There has been no change to our segment reporting.

We are scheduled to announce our Full Year 2021 results on Monday, 1 November 2021.

For further information:

David Lording Andrew Bowden
Group Head of Media Relations Head of Investor Relations
0419 683 411 0438 284 863

This document has been authorised for release by Tim Hartin, General Manager & Company Secretary.

Page 3 of 4

Appendix1 – Details of items affecting Westpac’s2H21 Financial Results

Summary 2H21 Cash Detail (pre tax)
earnings
(after tax)
Write-down of goodwill and other assets $965m <br><br>reduction In our annual impairment test, the valuation of our WIB division did<br> not support the carrying value of its assets (mostly intangibles). This was partly due to reducing risk in the division through the exit<br> of energy trading, consolidating our Asian operations and reducing our correspondent banking relationships which have all impacted earnings.<br> At the same time, medium term expectations of a prolonged low interest rate environment, subdued financial markets income and elevated<br> compliance expenses have impacted WIB’s earnings outlook. This has resulted in a write-down of $1,156m for assets, which is processed<br> through expenses. Assets written down include:<br><br> <br>·      $487m<br> of goodwill, which is all the goodwill in WIB;<br><br> <br>·      $344m<br> of capitalised software; and<br><br> <br>·      $325m<br> of other assets, mostly property leases.
Additional provisions for customer refunds payments, associated costs and litigation provisions $172m<br><br> reduction The ongoing review of customer remediation, litigation and regulatory<br> investigations has led to the following changes in provisions:<br><br> <br>·      Revenue:<br>a net benefit of $12m from the release of some provisions no longer required in Business partially offset by additional provisions in<br>Westpac New Zealand; and<br><br> <br>·     Expenses:<br> $215m for additional expenses in our remediation programs and for litigation matters, including to resolve outstanding investigations<br> should a regulator decide to bring civil penalty proceedings.
·      Separate to the above, we are also reviewing premium increases on certain life insurance products issued by Westpac Life Insurance Services Limited (WLIS). This review relates to Product Disclosure Statements for life insurance products issued in the years 2010 to 2017. This is a complex review where the outcomes are currently uncertain. As such, customer remediation may be required in the future. There is also a risk that the outcomes of the review could impact the financial and/or capital position of WLIS.
Asset sales and revaluations $182m<br><br> <br>reduction ·     Revenue<br> benefitted by $189m, from the gain on sale of Westpac General Insurance and post sale adjustments mainly related to our Vendor Finance<br> business, partly offset by a reduction relating to the sale of our shares in Coinbase Inc.<br><br> <br>·      Expenses<br> associated with asset sales and revaluations of $291m including costs related to the sale of WLIS and other divestment costs. These costs<br> were partially offset by a $60m reversal of previous write-downs related to Westpac Pacific as the sale is not currently proceeding.<br><br> <br>·    Tax<br> expense and Non-controlling interests (NCI) impacts of $140m related to gains on the above sales partly offset by tax benefits from transaction<br> and separation costs deductibility.

Page 4 of 4

Appendix2 – Summary of 2H21 and FY21 notable items

2H21<br> ($m) Consumer Business WIB New<br> Zealand<br> (in A) Specialist<br><br> Businesses Group<br><br> Businesses Total
Net interest<br> income 3 103 - (32 (18 ) - 56
Non-interest<br> income - - - (6 198 (47 ) 145
Operating<br> expenses (30 ) (19 ) (1,156 ) (17 (304 ) (76 ) (1,602 )
Core earnings (27 ) 84 **** (1,156 ) (55 (124 ) (123 ) (1,401 )
Income tax benefit/(expense) 3 (29 ) 191 13 (115 ) 23 86
NCI - - - - (4 ) - (4 )
Cash earnings (24 ) 55 **** (965 ) (42 (243 ) (100 ) (1,319 )

All values are in US Dollars.

2H21<br> ($m) Provisions<br> for<br><br> refunds, payments, <br><br> costs & litigation Write-down<br> of<br><br> goodwill and other<br><br> assets Asset<br> sales /<br><br> revaluations Total
Net interest income 60 - (4 ) 56
Non-interest income (48 ) - 193 145
Operating expenses (215 ) (1,156 ) (231 ) (1,602 )
Core earnings (203 ) (1,156 ) (42 ) (1,401 )
Income tax benefit/(expense) 31 191 (136 ) 86
NCI - - (4 ) (4 )
Cash earnings (172 ) (965 ) (182 ) (1,319 )
FY21<br> ($m) Consumer Business WIB New <br> Zealand<br> (in A) Specialist<br><br> Businesses Group<br><br> Businesses Total
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
Net<br> interest income 3 177 - ) (18 ) - 127
Non-interest<br> income (3 ) 1 - ) 199 331 517
Operating expenses (136 ) (59 ) (1,193 ) ) (640 ) (296 ) (2,347 )
Core earnings **** (136 ) **** 119 **** **** (1,193 ) ) **** (459 ) **** 35 **** **** (1,703 )
Income tax benefit/<br> (expense) 36 (39 ) 202 (84 ) (28 ) 104
NCI - - - 3 (5 ) (2 )
Cash earnings **** (100 ) **** 80 **** **** (991 ) ) **** (540 ) **** 2 **** **** (1,601 )

All values are in US Dollars.

FY21 ($m) Provisions<br> for<br><br> refunds, payments, <br><br> costs & litigation Write-down<br> of<br><br> goodwill and other <br><br> assets Asset sales<br> /<br><br> revaluations Total
Net interest income 131 - (4 ) 127
Non-interest income (247 ) - 764 517
Operating expenses (471 ) (1,405 ) (471 ) (2,347 )
Core earnings **** (587 ) **** (1,405 ) **** 289 **** **** (1,703 )
Income tax benefit/(expense) 139 241 (276 ) 104
NCI - - (2 ) (2 )
Cash earnings **** (448 ) **** (1,164 ) **** 11 **** **** (1,601 )